In order to prevent the patent thicket problem and follow-on patenting of minor modifications of existing inventions that extend patent protection and potential market monopoly, policymakers need to strengthen the novelty and obviousness standards
Buijs BS, Van Den Berk GE, Boateng CP, Hoepelman AI, Van Maarseveen EM, Arends JE
Glucagon-like-peptide-2 (GLP-2) is a similar compound that is typically not considered an incretin due to its lack of glycemic effects
Better approach: Choose one GHRP and combine it with a GHRH analog like CJC-1295 for true synergy
(2002) in the Journal of Clinical Endocrinology and Metabolism
I worked with so many clients who used both in the same skincare routine to get glower, younger-looking skin faster only to be hit with a bad case of irritation